HNO International Announces an 82% Reduction in Outstanding Shares of Common Stock as 360 Million Shares Have Been Exchanged
HNO International (HNOI) has announced a significant reduction in its outstanding common stock shares, with 360 million shares being exchanged for newly designated Series B Convertible Preferred Stock. This exchange, involving shares owned by CEO Donald Owens and an affiliated entity, has resulted in an 82% decrease in outstanding common shares, reducing the total to approximately 74 million shares.
The company, which specializes in hydrogen-based clean energy technologies, views this exchange as part of its transition from R&D to production operations. According to CEO Owens, this restructuring aims to enhance shareholder value while maintaining their focus on product development.
HNO International (HNOI) ha annunciato una significativa riduzione delle sue azioni ordinarie in circolazione, con 360 milioni di azioni scambiate per nuove azioni privilegiate convertibili di Serie B. Questo scambio, che coinvolge azioni detenute dal CEO Donald Owens e da un'entità affiliata, ha portato a una diminuzione dell'82% delle azioni ordinarie in circolazione, riducendo il totale a circa 74 milioni di azioni.
L'azienda, specializzata in tecnologie energetiche pulite basate sull'idrogeno, considera questo scambio come parte della sua transizione da R&D a operazioni di produzione. Secondo il CEO Owens, questa ristrutturazione mira a migliorare il valore per gli azionisti mantenendo al contempo il focus sullo sviluppo del prodotto.
HNO International (HNOI) ha anunciado una reducción significativa en sus acciones comunes en circulación, con 360 millones de acciones intercambiadas por nuevas acciones preferentes convertibles de la Serie B. Este intercambio, que involucra acciones propiedad del CEO Donald Owens y una entidad afiliada, ha resultado en una disminución del 82% en las acciones comunes en circulación, reduciendo el total a aproximadamente 74 millones de acciones.
La compañía, que se especializa en tecnologías de energía limpia basadas en hidrógeno, ve este intercambio como parte de su transición de I+D a operaciones de producción. Según el CEO Owens, esta reestructuración tiene como objetivo mejorar el valor para los accionistas mientras se mantiene el enfoque en el desarrollo de productos.
HNO International (HNOI)는 3억 6천만 주의 보통주를 새롭게 지정된 B 시리즈 전환 우선주로 교환하여 보통주가 크게 감소했다고 발표했습니다. 이 교환은 CEO 도널드 오웬스(Donald Owens)와 관련 단체가 보유한 주식을 포함하며, 82%의 줄어든 보통주가 약 7400만 주로 감소했습니다.
수소 기반 청정 에너지 기술을 전문으로 하는 이 회사는 이 교환을 연구 및 개발에서 생산 운영으로의 전환의 일환으로 보고 있습니다. 오웬스 CEO에 따르면, 이번 구조 조정은 제품 개발에 집중하면서 주주 가치를 높이는 것을 목표로 하고 있습니다.
HNO International (HNOI) a annoncé une réduction significative de ses actions ordinaires en circulation, avec 360 millions d'actions échangées contre de nouvelles actions privilégiées convertibles de série B. Cet échange, impliquant des actions détenues par le PDG Donald Owens et une entité affiliée, a entraîné une baisse de 82% des actions ordinaires en circulation, réduisant le total à environ 74 millions d'actions.
L'entreprise, qui se spécialise dans les technologies d'énergie propre à base d'hydrogène, considère cet échange comme une partie de sa transition de la R&D vers les opérations de production. Selon le PDG Owens, cette restructuration vise à améliorer la valeur pour les actionnaires tout en maintenant le focus sur le développement de produits.
HNO International (HNOI) hat eine signifikante Reduzierung seiner ausstehenden Stammaktien angekündigt, wobei 360 Millionen Aktien gegen neu bezeichnete Serie-B-Umwandlungs-Vorzugsaktien eingetauscht wurden. Dieser Austausch, der Aktien betrifft, die im Besitz von CEO Donald Owens und einer verbundenen Einheit sind, führte zu einem Rückgang von 82% der ausstehenden Stammaktien, wodurch die Gesamtzahl auf etwa 74 Millionen Aktien gesenkt wurde.
Das Unternehmen, das sich auf wasserstoffbasierte saubere Energietechnologien spezialisiert hat, sieht diesen Austausch als Teil seines Übergangs von F&E zu Produktionsbetrieb. Laut CEO Owens zielt diese Umstrukturierung darauf ab, den Wert für die Aktionäre zu steigern und gleichzeitig den Fokus auf die Produktentwicklung zu behalten.
- 82% reduction in outstanding common shares, decreasing from ~434M to 74M shares
- Successful transition from R&D to production phase
- Share restructuring potentially reduces dilution for common stockholders
- Large concentration of voting power in preferred shares held by CEO and affiliated entity
After the return exchange of 360 million shares of Common Stock owned by Donald Owens, Chairman of the Board of Directors and CEO of the Company and an affiliated entity, for shares of newly designated Series B Convertible Preferred Stock, the new number of outstanding shares of Common Stock is roughly 74 million shares.
"As 2024 ends and 2025 begins, I'm pleased to announce this share exchange. Our rotation from R&D to a production environment has placed the Company in a significantly stronger position and has enabled us to drastically reduce the outstanding shares of Common Stock of the Company through this exchange, furthering our goal of bringing both a solid product and increasing shareholder value to the marketplace," commented Donald Owens, Chairman of the Board of Directors and CEO of HNO International.
About HNO International
HNO International (HNOI) is a company specializing in the design, integration, and development of green hydrogen-based energy technologies. With over 15 years of experience in green hydrogen production, HNOI and its leadership team are on a mission to help lead the renewable energy transition by making energy accessible to businesses and communities worldwide. Their pioneering solutions, including the Scalable Hydrogen Energy Platform (SHEP™) and the Compact Hydrogen Refueling Station (CHRS™), are setting new standards for green hydrogen production.
Forward-Looking Statements
This news release contains "forward-looking statements" which are not purely historical and may include any statements regarding beliefs, plans, expectations or intentions regarding the future. Such forward-looking statements include, among other things, the development, costs and results of new business opportunities and words such as "anticipate", "seek", intend", "believe", "estimate", "plan", or similar phrases may be deemed "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Actual results could differ from those projected in any forward-looking statements due to numerous factors. These forward-looking statements are made as of the date of this news release, and we assume no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those projected in the forward-looking statements. Investors should consult all of the information set forth herein and should also refer to the risk factors disclosure outlined in our annual report on Form 10-K, our quarterly reports on Form 10-Q and other periodic reports filed from time to time with the Securities and Exchange Commission. For more information, please visit www.sec.gov.
View original content to download multimedia:https://www.prnewswire.com/news-releases/hno-international-announces-an-82-reduction-in-outstanding-shares-of-common-stock-as-360-million-shares-have-been-exchanged-302341629.html
SOURCE HNO International
FAQ
What is the impact of HNOI's 82% share reduction on existing shareholders?
How many HNOI shares were exchanged in January 2025?
What is HNOI's new share count after the January 2025 exchange?
How does HNOI's transition from R&D to production relate to the share exchange?
